Dr. Saccomano joined the KromaTiD board in 2016. He has served as Chief Scientific Officer of Array BioPharma (Boulder, CO) since May 2014. Dr. Saccomano is a seasoned leader with 30 years of experience in pharmaceutical and biotechnology research and development, with expertise in discovery research, clinical development, portfolio strategy, technology and clinical candidate licensing, and scientific partnering. Dr. Saccomano previously was CTO at SomaLogic, Inc. and before that CSO at Bend Research Inc. Prior to Bend Research, held positions of increasing responsibility at Pfizer, Inc., including Senior VP in R&D and VP of Discovery Technology, where he managed and developed enabling technologies used broadly across the drug discovery pipeline. During his tenure, he also directed medicinal sciences, drug discovery and strategic alliances. Dr. Saccomano obtained his Ph.D. in chemistry from Columbia University.